295 related articles for article (PubMed ID: 8480376)
1. Current perspectives on anabolic-androgenic steroid abuse.
Lukas SE
Trends Pharmacol Sci; 1993 Feb; 14(2):61-8. PubMed ID: 8480376
[TBL] [Abstract][Full Text] [Related]
2. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
Bahrke MS; Yesalis CE
Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
[TBL] [Abstract][Full Text] [Related]
3. Anabolic-androgenic steroids: use and abuse in pediatric patients.
Kerr JM; Congeni JA
Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
[TBL] [Abstract][Full Text] [Related]
4. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology.
Eklöf AC; Thurelius AM; Garle M; Rane A; Sjöqvist F
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):571-7. PubMed ID: 13680032
[TBL] [Abstract][Full Text] [Related]
5. Human growth hormone abuse in male weightlifters.
Brennan BP; Kanayama G; Hudson JI; Pope HG
Am J Addict; 2011; 20(1):9-13. PubMed ID: 21175915
[TBL] [Abstract][Full Text] [Related]
6. Anabolic-androgenic steroids and adolescents: recent developments.
Denham BE
J Addict Nurs; 2012 Oct; 23(3):167-71, quuiz 172-3. PubMed ID: 24335733
[TBL] [Abstract][Full Text] [Related]
7. The use of anabolic androgenic steroids and polypharmacy: a review of the literature.
Dodge T; Hoagland MF
Drug Alcohol Depend; 2011 Apr; 114(2-3):100-9. PubMed ID: 21232881
[TBL] [Abstract][Full Text] [Related]
8. Use of steroids for self-enhancement: an epidemiologic/societal perspective.
Yesalis CE
AIDS Read; 2001 Mar; 11(3):157-60. PubMed ID: 17004353
[TBL] [Abstract][Full Text] [Related]
9. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
[TBL] [Abstract][Full Text] [Related]
10. Anabolic-androgenic steroid dependence? Insights from animals and humans.
Wood RI
Front Neuroendocrinol; 2008 Oct; 29(4):490-506. PubMed ID: 18275992
[TBL] [Abstract][Full Text] [Related]
11. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
Curry LA; Wagman DF
Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
[TBL] [Abstract][Full Text] [Related]
12. ACOG Committee Opinion No. 484: Performance enhancing anabolic steroid abuse in women.
Obstet Gynecol; 2011 Apr; 117(4):1016-1018. PubMed ID: 21422881
[TBL] [Abstract][Full Text] [Related]
13. Are anabolic-androgenic steroid users polysubstance users?
Dunn M
J Sci Med Sport; 2009 Nov; 12(6):e1-2. PubMed ID: 19119065
[No Abstract] [Full Text] [Related]
14. Androgenic Steroids Use and Abuse: Past, Present, and Future.
Thirumalai A; Anawalt BD
Urol Clin North Am; 2022 Nov; 49(4):645-663. PubMed ID: 36309421
[TBL] [Abstract][Full Text] [Related]
15. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxic effects of cocaine and anabolic-androgenic steroids in the athlete.
Welder AA; Melchert RB
J Pharmacol Toxicol Methods; 1993 Apr; 29(2):61-8. PubMed ID: 8318715
[TBL] [Abstract][Full Text] [Related]
17. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
Anawalt BD
Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
[TBL] [Abstract][Full Text] [Related]
18. The use of anabolic-androgenic steroids by Canadian students.
Melia P; Pipe A; Greenberg L
Clin J Sport Med; 1996 Jan; 6(1):9-14. PubMed ID: 8925377
[TBL] [Abstract][Full Text] [Related]
19. Steroid and nutritional supplement use in professional athletes.
Millman RB; Ross EJ
Am J Addict; 2003; 12(s2):S48-S54. PubMed ID: 12857663
[TBL] [Abstract][Full Text] [Related]
20. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.
Deshmukh N; Petróczi A; Barker J; Székely AD; Hussain I; Naughton DP
Subst Abuse Treat Prev Policy; 2010 Apr; 5():7. PubMed ID: 20429943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
